Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy

Published:2018 Issue:3 Volume:10 Page:193-201
ISSN:1689-832X
Container-title:Journal of Contemporary Brachytherapy
language:
Short-container-title:jcb

Author:

Chapman Christopher H.,Braunstein Steve E.,Pouliot Jean,Noworolski Susan M.,Weinberg Vivian,Cunha Adam,Kurhanewicz John,Gottschalk Alexander R.,III Mack Roach,Hsu I-Chow

Publisher

Termedia Sp. z.o.o.

Subject

Radiology Nuclear Medicine and imaging,Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy based microboosting to the dominant intraprostatic lesion in prostate cancer: A systematic review on treatment outcomes and toxicities;Brachytherapy;2024-09

2. Viability of focal dose escalation to prostate cancer intraprostatic lesions using HDR prostate brachytherapy;Brachytherapy;2023-11

3. Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation with Toxicity;Advances in Radiation Oncology;2023-05

4. Integrating external beam and prostate seed implant dosimetry for intermediate and high-risk prostate cancer using biologically effective dose: Impact of image registration technique;Brachytherapy;2022-11

5. In vivo dosimetry in pelvic brachytherapy;The British Journal of Radiology;2022-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP